Medical College Of Wisconsin
Clinical trials sponsored by Medical College Of Wisconsin, explained in plain language.
-
HIV drug could be breakthrough for millions with untreatable throat condition
Disease control Not yet recruitingThis study is testing whether an existing HIV medication can help people with laryngopharyngeal reflux (LPR), a common throat condition that causes chronic cough, hoarseness, and throat clearing. Researchers will give 104 adults with LPR either the HIV drug fosamprenavir or a pla…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 04, 2026 02:34 UTC
-
Brain 'Remapping' implant could let surgeons cut out more cancer
Disease control Not yet recruitingThis pilot study is testing a new approach to help surgeons remove more of a brain tumor while protecting critical functions like movement and speech. Researchers will implant a small device that gently stimulates the brain to temporarily weaken a function, while physical therapy…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Could a simple supplement help treat dangerous pregnancy condition?
Disease control Not yet recruitingThis study is testing whether MitoQ, a nutritional supplement that acts as an antioxidant, can improve blood vessel function in pregnant women with preeclampsia. Researchers will enroll 80 women with preeclampsia to see if MitoQ helps restore healthy blood flow, improves placenta…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Diabetes drug tested to fight fatty liver disease
Disease control Not yet recruitingThis study aims to see if a common type of diabetes drug (GLP-1 RA) can improve the buildup of harmful fats in the liver of people who have fatty liver disease, diabetes, and obesity. Researchers will compare liver and blood samples from 30 people who have been on the drug for a …
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug trial targets aggressive prostate cancer in men out of options
Disease control Not yet recruitingThis study is testing an oral drug called pacritinib for men with advanced prostate cancer that has spread and is no longer responding to standard hormone-blocking treatments. About 32 participants will take the drug twice daily to see if it can slow the cancer's growth. The main…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New 'Living Drug' trial offers hope for patients out of options
Disease control Not yet recruitingThis is an early-stage study testing the safety of a new type of treatment called FT836 CAR T-cell therapy, given alongside an existing drug called daratumumab. It is for adults with advanced multiple myeloma that has come back or stopped responding to at least three prior treatm…
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Prescription for a song: could singing be the next heart therapy?
Disease control Not yet recruitingThis study is preparing for a larger trial to see if regular singing can improve blood vessel health and lower future heart disease risk in older adults who already have coronary artery disease. Researchers will test whether group singing (in-person or virtual) or solo singing is…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Could a simple gut acid hold the key to better heart health?
Disease control Not yet recruitingThis study is testing whether a dietary supplement called propionic acid can improve blood vessel function in people with coronary artery disease. Researchers want to see if this gut-derived acid reduces inflammation and helps blood vessels work better. The study will enroll 20 p…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New Two-Pronged Cancer-Fighting cell therapy enters first human safety trial
Disease control Not yet recruitingThis is a first-in-human study to test the safety of a new type of CAR-T cell therapy for adults with B-cell cancers like lymphoma that have come back or stopped responding to other treatments. The therapy uses a patient's own modified immune cells designed to attack cancer by ta…
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for elderly lymphoma patients: trial tests shorter, targeted treatment
Disease control Not yet recruitingThis study is testing whether adding two newer drugs, mosunetuzumab and polatuzumab vedotin, to a modified chemotherapy regimen can better treat aggressive lymphoma in older adults. The goal is to see if this combination improves the chance of a complete response and allows some …
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New vaccine trial targets cancer that spreads to the brain
Disease control Not yet recruitingThis early-stage study is testing whether a new vaccine, combined with an existing immunotherapy drug, is safe and practical for patients whose cancer has spread to the brain or spinal fluid. It will involve about 20 patients whose cancer has worsened despite standard treatments.…
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Can virtual classes help puerto rican men shed pounds?
Disease control Not yet recruitingThis study is testing if a virtual lifestyle program tailored for Puerto Rican men can help them lose weight. Researchers will compare a program focused on healthy eating and physical activity to one giving only general health information. The goal is to see if the culturally rel…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope when CAR-T fails: trial tests Next-Gen treatment for tough myeloma cases
Disease control Not yet recruitingThis study is testing an experimental drug called linvoseltamab for people with multiple myeloma whose cancer has returned after receiving a specific type of CAR-T cell therapy. The trial aims to see if this new treatment can help control the disease and is safe for these patient…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Can a common supplement protect your tiny blood vessels?
Disease control Not yet recruitingThis study is testing whether quercetin, a natural supplement, can help protect and improve the function of tiny blood vessels in people with obesity. Researchers will enroll 40 obese adults aged 18-40 and measure their blood vessel responses before and after taking the supplemen…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New computer aid aims to shield cancer survivors from heart damage
Disease control Not yet recruitingThis study is testing a new computer-based decision tool designed to help doctors better protect cancer survivors from heart problems. The tool will be tested with 60 cancer survivors who are at risk for heart disease. Researchers want to see if the tool is easy for doctors and p…
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Can a simple fluid flush during labor prevent newborn breathing crises?
Disease control Not yet recruitingThis study is testing whether adding warm, sterile fluid into the womb during labor can help protect newborns from serious breathing problems. It will enroll 320 pregnant people who have thick meconium (baby's first stool) in their amniotic fluid, which can cause breathing issues…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
First patients sought for trial of 'Re-Engineered' immune cells to fight advanced blood cancers
Disease control Not yet recruitingThis is a first-in-human study to test the safety and early effectiveness of a new personalized immunotherapy. It is for adults with certain advanced blood cancers (like Hodgkin lymphoma and others) that have a marker called CD30 and have come back or not responded to at least tw…
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Can diet and exercise classes before pregnancy prevent complications?
Prevention Not yet recruitingThis study aims to see if providing healthy lifestyle education about diet, exercise, and nutrition to women before they get pregnant or in early pregnancy can improve their heart health and lower the risk of pregnancy complications like gestational diabetes and preeclampsia. Res…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Mar 31, 2026 12:11 UTC
-
Old drug, new hope: can a gallstone pill stop a dangerous gut infection?
Prevention Not yet recruitingThis early-stage study is testing if adding a bile acid pill called Ursodeoxycholic Acid (UDCA) to standard antibiotic treatment can prevent C. difficile (C. diff) infection from returning. It will enroll 30 high-risk adults who have just been treated for C. diff. The goal is to …
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC
-
Can mindfulness stop dangerous pregnancy condition? new study investigates
Prevention Not yet recruitingThis study is testing whether mindfulness training, with or without wearable sensors, can help prevent preeclampsia—a serious high blood pressure disorder during pregnancy. Researchers will enroll 90 pregnant women at risk for this condition and randomly assign them to receive mi…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC
-
Blood test trial aims to stop dangerous Post-Birth condition
Prevention Not yet recruitingThis pilot study aims to prevent serious health problems from postpartum preeclampsia, a dangerous high blood pressure condition that can start after childbirth. Researchers will test a blood marker to identify 60 at-risk pregnant women in Nepal. Women flagged as high-risk may re…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Shining a light on cancer Kids' pain: study tests gentle therapy for agonizing mouth sores
Symptom relief Not yet recruitingThis study aims to see if a gentle light therapy can prevent and treat painful mouth sores (mucositis) in children receiving cancer treatment. Researchers will enroll 50 children and compare those receiving the light therapy every other day during hospital stays to past patients …
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Apr 04, 2026 02:20 UTC
-
New hope for stubborn heartburn? experimental pill enters testing
Symptom relief Not yet recruitingThis study is testing whether a new oral medication called FOS-SA can reduce symptoms in people with persistent acid reflux disease (GERD) that doesn't get better with standard heartburn pills. About 60 participants will take either the study drug or a placebo twice daily for 8 w…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Zap to the back: can electrical stimulation restore balance after spinal surgery?
Symptom relief Not yet recruitingThis study is testing whether a non-invasive electrical stimulation treatment, applied to the spine, can help improve balance in adults who continue to have stability problems after surgery for a degenerative neck spinal cord condition. Participants will be randomly assigned to r…
Phase: PHASE1, PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Can diet and exercise help fight myeloma symptoms?
Symptom relief Not yet recruitingThis study is testing whether a 16-week lifestyle program focused on diet and exercise can help improve physical function and quality of life for people living with multiple myeloma. Researchers will enroll 184 adults who have been diagnosed for at least one year and are medicall…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
New hope for veterans battling brain injury symptoms
Symptom relief Not yet recruitingThis study is testing whether a 3-week outpatient rehabilitation program can reduce long-lasting symptoms from traumatic brain injuries and related conditions in veterans and first responders. Researchers will compare participants who receive the program to those who don't, measu…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Mar 12, 2026 13:51 UTC
-
Scientists probe why exercise turns dangerous for diabetics
Knowledge-focused Not yet recruitingThis study aims to understand why people with type 2 diabetes often experience dangerous blood pressure spikes during exercise, which increases their risk of heart attacks and strokes. Researchers will measure blood pressure, heart rate, and blood vessel function in 40 participan…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Apr 04, 2026 02:25 UTC
-
Can a simple blood test predict weight regain?
Knowledge-focused Not yet recruitingThis study aims to understand why some people regain weight after stopping popular injectable weight loss drugs. Researchers will measure a brain protein and other body metrics in 52 adults before and after they stop their medication due to insurance changes. The goal is to ident…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Scientists launch massive blood sample bank to unlock secrets of transplants and gene therapy
Knowledge-focused Not yet recruitingThis study aims to create a large collection of blood samples and health information from patients receiving stem cell transplants or gene therapy for serious non-cancer blood diseases like aplastic anemia and sickle cell disease. Researchers will collect samples before and after…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Can a DNA test nudge you to prevent a heart attack?
Knowledge-focused Not yet recruitingThis study aims to see if adding a genetic risk score to standard heart disease check-ups helps patients and doctors in everyday clinics make better decisions about starting preventive medication. Researchers will enroll 200 adults without heart disease from one rural and one urb…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
Are diet drinks hurting young hearts? new study investigates
Knowledge-focused Not yet recruitingThis study aims to understand if consuming sugar-free sweeteners (like those in diet sodas) affects heart and blood vessel health in young adults with type 1 diabetes. Researchers will measure sweetener levels in the blood and check blood vessel function in 20 participants after …
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC